Skip to content

Analysis of clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.

Analysis of clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome. - Analysis of colorectal tumors with MSI including Lynch syndrome.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025142
Enrollment
20
Registered
2017-01-01
Start date
2016-12-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lynch syndrome Colorectal tumor

Interventions

None listed

Sponsors

Tokushima University Hospital, Department of Gastroenterology and Oncology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Lynch syndrome patients who meet the Amsterdam criteria and the revised Bethesda guidelines.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.

Countries

Japan

Contacts

Public ContactFumika Nakamura

Tokushima University Graduate School, The Institute of Biomedical Sciences, Department of Gastroente Gastroenterology and Oncology

fumiofumio@hotmail.com088-633-7122

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026